This event begins in
  • Days
  • Hours
  • Minutes
A zoom link will be available the day of the event.
  • September 18, 2025
  • 6:30 PM EST - 8:00 PM EST
  • 1 Hour 30 Minutes

National Cornerstone Corner, 6:30 PM

National Cornerstone Corner, 6:30 PM

Redefining the Treatment of Squamous Cell Carcinoma of the Anal Canal (SCAC) | ZYNYZ (retifanlimab-dlwr): The First and Only FDA-Approved PD-1 Inhibitor for Adults with Inoperable Locally Recurrent or Metastatic SCAC

Program Chairs

Dr. Mohammed Al Hallak

Sponsors

 

This program is not CME accredited.
In addition to the Program's educational offerings, a separate portion involves market research sessions for which a fair market value honorarium will be offered to eligible registrants who choose to participate. Additional details are listed on the registration page and dependent on registrant's designation.